Stock Quote
ResMed Inc. (RMD) (NYSE Arca)
$50.39
3:16pm EST
+0.28%
$50.25
$50.50
231,301
$51.00
$50.24
$51.64
$31.49
0.55
750,129
RMD
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Farrell, Peter | Executive Chairman of the Board | 2,830,610 |
| Gallahue, Kieran | President, Chief Executive Officer, Director | 3,467,270 |
| Sandercock, Brett | Chief Financial Officer | 1,267,060 |
Profile
ResMed Inc. is a holding company. Through its subsidiaries, the Company develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea (OSA). It has developed nasal... Full Description
Company Address
ResMed Inc.
14040 Danielson Street
Poway CA 92064
P: +1858.7462400
F: +1858.6222043
14040 Danielson Street
Poway CA 92064
P: +1858.7462400
F: +1858.6222043
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Koninklijke Philips Electronics NV | €18.53 | +0.52 |
| Covidien PLC | $46.25 | +0.60 |
| Fisher & Paykel Healthcare Corp. Limited | $3.21 | +0.02 |
| RMD | Industry | |
|---|---|---|
| P/E(TTM) | 24.10 | 7.62 |
| P/S(TTM) | 3.97 | 0.46 |
| ROI(TTM) | 13.13 | 0.98 |
| ROE(TTM) | 14.75 | 1.52 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 0.58 |
| EPS Est. (Current Year) | 1.93 |
| Total Revenue | $246.99M |
| Net Income | $42.10M |
| EPS | $0.55 |
